Stock CMH CHORDATE MEDICAL HOLDING AB
Add to a list
To use this feature you must be a member
Log inSign up

Chordate Medical Holding AB Stock

Equities

CMH

SE0009495559

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-04 pm EDT 		5-day change 1st Jan Change
0.057 SEK -4.68% Intraday chart for Chordate Medical Holding AB -9.81% -64.46%
Jun. 13 Chordate Medical Holding AB Enters New Partnership Agreement with Neurolite AG CI
Jun. 13 Chordate Medical Holding AB (OM:CMH) signed an agreement to acquire Neurolite. CI

Financials

Sales 2022 109K 10.35K Sales 2023 1.75M 167K Capitalization 37.28M 3.56M
Net income 2022 -27M -2.58M Net income 2023 -29M -2.77M EV / Sales 2022 723 x
Net cash position 2022 3.68M 351K Net cash position 2023 8.46M 807K EV / Sales 2023 16.5 x
P/E ratio 2022
-2.89 x
P/E ratio 2023
-1.23 x
Employees 3
Yield 2022 *
-
Yield 2023
-
Free-Float 46.01%
More Fundamentals * Assessed data

Chart Chordate Medical Holding AB

Dynamic Chart

Latest news about Chordate Medical Holding AB

Chordate Medical Holding AB Enters New Partnership Agreement with Neurolite AG CI
Chordate Medical Holding AB (OM:CMH) signed an agreement to acquire Neurolite. CI
Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Chordate Medical Receives Patent Approval in the US CI
Chordate Medical Holding AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Chordate Medical Holding AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Chordate Medical Gains EU Patent for Chronic Migraine Treatment MT
Chordate Medical Holding AB Announces the European Patent Office Grants New Patent CI
Chordate Medical Holding AB Signs Agreement with German Clinic for the Ozilia Treatment for Chronic Migraine CI
Chordate Medical Completes Training of Clinic Staff and Assists in Initiation of Treatment for First Three Patients at the Private Clinic in Hamburg CI
Chordate Medical Holding AB Announces First Patients Included in the Post-Market Study PM010 CI
Chordate Medical Holding AB Announces First Patient Included in the Company's Open Pilot Study PM009 CI
Chordate Medical Holding AB Receives First Installation of the Ozilia Migraine Treatment at a Private Clinic in Hamburg CI
Chordate Medical Holding AB Announces Post-Market Study of Chordate's Ozilia® Migraine Treatment Has Commenced in Four Different Markets CI
Chordate Medical Holding AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
More news

Press releases Chordate Medical Holding AB

Chordate Medical receives first order from Switzerland worth approximately KSEK 370 AQ
BioStock: Chordate Medical enters agreement in Switzerland AQ
Chordate Enters New Partnership Agreement with Neurolite, Switzerland – Adjusts List of Focus Markets AQ
Kalqyl in updated Analysis of Chordate Medical: "Making Progress in All Areas of the Market Plan" AQ
Chordate Medical's CEO to BioStock: "We are building step by step" AQ
More press releases

Quotes and Performance

1 day-4.68%
1 week-9.81%
Current month-9.24%
1 month+9.62%
3 months-9.81%
6 months-60.85%
Current year-64.46%
More quotes

Highs and lows

1 week
0.06
Extreme 0.057
0.07
1 month
0.05
Extreme 0.0492
0.09
Current year
0.05
Extreme 0.0462
0.24
1 year
0.05
Extreme 0.0462
0.46
3 years
0.05
Extreme 0.0462
3.39
5 years
0.05
Extreme 0.0462
5.56
10 years
0.05
Extreme 0.0462
14.00
More quotes

Managers and Directors - Chordate Medical Holding AB

Managers TitleAgeSince
Anders Henrik Weilandt CEO
 Chief Executive Officer 63 14-10-31
Niklas Lindecrantz DFI
 Director of Finance/CFO 56 17-10-01
Jan Hermansson CTO
 Chief Tech/Sci/R&D Officer 68 11-12-31
Members of the board TitleAgeSince
Jan Tommy Lennart Hedberg BRD
 Director/Board Member 69 14-05-31
Gunilla Lundmark BRD
 Director/Board Member 61 17-03-31
Anders Henrik Weilandt CEO
 Chief Executive Officer 63 14-10-31
More insiders

Quotes

Date Price Change Volume
24-07-04 0.057 -4.68% 604,419
24-07-03 0.0598 -9.39% 953,712
24-07-02 0.066 -1.79% 167,153
24-07-01 0.0672 +7.01% 455,280
24-06-28 0.0628 -0.63% 1,808,958

Delayed Quote Nasdaq Stockholm, July 04, 2024 at 12:00 pm EDT

More quotes

Company Profile

Chordate Medical Holding AB (publ) is a medical technology company based in Sweden. The Company develops treatment method through nerve stimulation for chronic nasal congestion. The Company’s headquartered is located in Kista, Sweden.
Sector
Advanced Medical Equipment & Technology
Calendar
2024-08-30 - Q2 2024 Earnings Release
More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
CHORDATE MEDICAL HOLDING AB Stock Chordate Medical Holding AB
-64.46% 2.65M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+0.91% 204B
DANAHER CORPORATION Stock Danaher Corporation
+3.74% 178B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+28.89% 154B
BOSTON SCIENTIFIC CORPORATION Stock Boston Scientific Corporation
+31.66% 112B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+1.37% 64.32B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+19.45% 54.88B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
-2.27% 47.24B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-9.28% 36.8B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
-0.10% 35.26B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. CMH Stock